A citation-based method for searching scientific literature

Oluwole Fadare, Fattaneh A Tavassoli. Adv Anat Pathol 2007
Times Cited: 64







List of co-cited articles
400 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
Torsten O Nielsen, Forrest D Hsu, Kristin Jensen, Maggie Cheang, Gamze Karaca, Zhiyuan Hu, Tina Hernandez-Boussard, Chad Livasy, Dave Cowan, Lynn Dressler,[...]. Clin Cancer Res 2004
67

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
64

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
59

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
Chad A Livasy, Gamze Karaca, Rita Nanda, Maria S Tretiakova, Olufunmilayo I Olopade, Dominic T Moore, Charles M Perou. Mod Pathol 2006
747
56

Repeated observation of breast tumor subtypes in independent gene expression data sets.
Therese Sorlie, Robert Tibshirani, Joel Parker, Trevor Hastie, J S Marron, Andrew Nobel, Shibing Deng, Hilde Johnsen, Robert Pesich, Stephanie Geisler,[...]. Proc Natl Acad Sci U S A 2003
46

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
E A Rakha, T C Putti, D M Abd El-Rehim, C Paish, A R Green, D G Powe, A H Lee, J F Robertson, I O Ellis. J Pathol 2006
238
39

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
39

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast.
L G Fulford, D F Easton, J S Reis-Filho, A Sofronis, C E Gillett, S R Lakhani, A Hanby. Histopathology 2006
246
39

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.
Laura G Fulford, Jorge S Reis-Filho, Ken Ryder, Chris Jones, Cheryl E Gillett, Andrew Hanby, Douglas Easton, Sunil R Lakhani. Breast Cancer Res 2007
225
32

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
Maggie C U Cheang, David Voduc, Chris Bajdik, Samuel Leung, Steven McKinney, Stephen K Chia, Charles M Perou, Torsten O Nielsen. Clin Cancer Res 2008
838
32

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
Lisa A Carey, E Claire Dees, Lynda Sawyer, Lisa Gatti, Dominic T Moore, Frances Collichio, David W Ollila, Carolyn I Sartor, Mark L Graham, Charles M Perou. Clin Cancer Res 2007
31

Basal-like breast carcinomas: clinical outcome and response to chemotherapy.
S Banerjee, J S Reis-Filho, S Ashley, D Steele, A Ashworth, S R Lakhani, I E Smith. J Clin Pathol 2006
205
29


Breast cancer molecular subtypes respond differently to preoperative chemotherapy.
Roman Rouzier, Charles M Perou, W Fraser Symmans, Nuhad Ibrahim, Massimo Cristofanilli, Keith Anderson, Kenneth R Hess, James Stec, Mark Ayers, Peter Wagner,[...]. Clin Cancer Res 2005
26

Gene expression profiling predicts clinical outcome of breast cancer.
Laura J van 't Veer, Hongyue Dai, Marc J van de Vijver, Yudong D He, Augustinus A M Hart, Mao Mao, Hans L Peterse, Karin van der Kooy, Matthew J Marton, Anke T Witteveen,[...]. Nature 2002
26

Breast cancer classification and prognosis based on gene expression profiles from a population-based study.
Christos Sotiriou, Soek-Ying Neo, Lisa M McShane, Edward L Korn, Philip M Long, Amir Jazaeri, Philippe Martiat, Steve B Fox, Adrian L Harris, Edison T Liu. Proc Natl Acad Sci U S A 2003
25

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.
Mervi Jumppanen, Sofia Gruvberger-Saal, Päivikki Kauraniemi, Minna Tanner, Pär-Ola Bendahl, Mikael Lundin, Morten Krogh, Pasi Kataja, Ake Borg, Mårten Fernö,[...]. Breast Cancer Res 2007
101
23

Expression of luminal and basal cytokeratins in human breast carcinoma.
Dalia M Abd El-Rehim, Sarah E Pinder, Claire E Paish, J Bell, R W Blamey, John F R Robertson, Robert I Nicholson, Ian O Ellis. J Pathol 2004
389
23

Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes.
Chris Jones, Emily Ford, Cheryl Gillett, Ken Ryder, Samantha Merrett, Jorge S Reis-Filho, Laura G Fulford, Andrew Hanby, Sunil R Lakhani. Clin Cancer Res 2004
122
23

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.
William D Foulkes, Ingunn M Stefansson, Pierre O Chappuis, Louis R Bégin, John R Goffin, Nora Wong, Michel Trudel, Lars A Akslen. J Natl Cancer Inst 2003
702
23

Basal-like breast cancer: a critical review.
Emad A Rakha, Jorge S Reis-Filho, Ian O Ellis. J Clin Oncol 2008
612
23

p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas.
Irina Matos, Rozany Dufloth, Marcelo Alvarenga, Luiz Carlos Zeferino, Fernando Schmitt. Virchows Arch 2005
179
21

Basal-like breast cancer and the BRCA1 phenotype.
N C Turner, J S Reis-Filho. Oncogene 2006
322
21

Metaplastic breast carcinomas are basal-like tumours.
J S Reis-Filho, F Milanezi, D Steele, K Savage, P T Simpson, J M Nesland, E M Pereira, S R Lakhani, F C Schmitt. Histopathology 2006
236
21

Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors.
Mervi Laakso, Niklas Loman, Ake Borg, Jorma Isola. Mod Pathol 2005
132
21

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.
Bas Kreike, Marieke van Kouwenhove, Hugo Horlings, Britta Weigelt, Hans Peterse, Harry Bartelink, Marc J van de Vijver. Breast Cancer Res 2007
429
21

Triple negative tumours: a critical review.
J S Reis-Filho, A N J Tutt. Histopathology 2008
644
21

Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression.
E A Rakha, M E El-Sayed, A R Green, E C Paish, A H S Lee, I O Ellis. Histopathology 2007
123
20

A gene-expression signature as a predictor of survival in breast cancer.
Marc J van de Vijver, Yudong D He, Laura J van't Veer, Hongyue Dai, Augustinus A M Hart, Dorien W Voskuil, George J Schreiber, Johannes L Peterse, Chris Roberts, Matthew J Marton,[...]. N Engl J Med 2002
20

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients.
Stefano Calza, Per Hall, Gert Auer, Judith Bjöhle, Sigrid Klaar, Ulrike Kronenwett, Edison T Liu, Lance Miller, Alexander Ploner, Johanna Smeds,[...]. Breast Cancer Res 2006
181
20

Prognostic markers in triple-negative breast cancer.
Emad A Rakha, Maysa E El-Sayed, Andrew R Green, Andrew H S Lee, John F Robertson, Ian O Ellis. Cancer 2007
891
20

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome.
Matt van de Rijn, Charles M Perou, Rob Tibshirani, Phillippe Haas, Olli Kallioniemi, Juha Kononen, Joachim Torhorst, Guido Sauter, Markus Zuber, Ossi R Köchli,[...]. Am J Pathol 2002
433
20

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
Antonio C Wolff, M Elizabeth H Hammond, Jared N Schwartz, Karen L Hagerty, D Craig Allred, Richard J Cote, Mitchell Dowsett, Patrick L Fitzgibbons, Wedad M Hanna, Amy Langer,[...]. J Clin Oncol 2007
20

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.
François Bertucci, Pascal Finetti, Nathalie Cervera, Emmanuelle Charafe-Jauffret, Emilie Mamessier, José Adélaïde, Stéphane Debono, Gilles Houvenaeghel, Dominique Maraninchi, Patrice Viens,[...]. Cancer Res 2006
198
18

Typical medullary breast carcinomas have a basal/myoepithelial phenotype.
Jocelyne Jacquemier, Laetitia Padovani, Laetitia Rabayrol, Sunil R Lakhani, Frédérique Penault-Llorca, Yves Denoux, Maryse Fiche, Paulo Figueiro, Véronique Maisongrosse, Viviane Ledoussal,[...]. J Pathol 2005
139
18

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.
Sunil R Lakhani, Jorge S Reis-Filho, Laura Fulford, Frederique Penault-Llorca, Marc van der Vijver, Suzanne Parry, Timothy Bishop, Javier Benitez, Carmen Rivas, Yves-Jean Bignon,[...]. Clin Cancer Res 2005
445
18

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer.
Marc Tischkowitz, Jean-Sébastien Brunet, Louis R Bégin, David G Huntsman, Maggie C U Cheang, Lars A Akslen, Torsten O Nielsen, William D Foulkes. BMC Cancer 2007
291
18

Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice.
Leslie K Diaz, Vincent L Cryns, W Fraser Symmans, Nour Sneige. Adv Anat Pathol 2007
85
18


Concordance among gene-expression-based predictors for breast cancer.
Cheng Fan, Daniel S Oh, Lodewyk Wessels, Britta Weigelt, Dimitry S A Nuyten, Andrew B Nobel, Laura J van't Veer, Charles M Perou. N Engl J Med 2006
943
17


Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.
Emad A Rakha, Dalia Abd El-Rehim, Claire Paish, Andrew R Green, Andrew H S Lee, John F Robertson, Roger W Blamey, Douglas Macmillan, Ian O Ellis. Eur J Cancer 2006
158
15

The molecular portraits of breast tumors are conserved across microarray platforms.
Zhiyuan Hu, Cheng Fan, Daniel S Oh, J S Marron, Xiaping He, Bahjat F Qaqish, Chad Livasy, Lisa A Carey, Evangeline Reynolds, Lynn Dressler,[...]. BMC Genomics 2006
967
15

Clinical and pathologic aspects of basal-like breast cancers.
Oluwole Fadare, Fattaneh A Tavassoli. Nat Clin Pract Oncol 2008
70
15

Triple-negative breast cancer: clinical features and patterns of recurrence.
Rebecca Dent, Maureen Trudeau, Kathleen I Pritchard, Wedad M Hanna, Harriet K Kahn, Carol A Sawka, Lavina A Lickley, Ellen Rawlinson, Ping Sun, Steven A Narod. Clin Cancer Res 2007
15


BRCA1 dysfunction in sporadic basal-like breast cancer.
N C Turner, J S Reis-Filho, A M Russell, R J Springall, K Ryder, D Steele, K Savage, C E Gillett, F C Schmitt, A Ashworth,[...]. Oncogene 2007
420
15

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.
Anne Vincent-Salomon, Nadège Gruel, Carlo Lucchesi, Gaëtan MacGrogan, Remi Dendale, Brigitte Sigal-Zafrani, Michel Longy, Virginie Raynal, Gaëlle Pierron, Isabelle de Mascarel,[...]. Breast Cancer Res 2007
125
14

Differences in risk factors for breast cancer molecular subtypes in a population-based study.
Xiaohong R Yang, Mark E Sherman, David L Rimm, Jolanta Lissowska, Louise A Brinton, Beata Peplonska, Stephen M Hewitt, William F Anderson, Neonila Szeszenia-Dabrowska, Alicja Bardin-Mikolajczak,[...]. Cancer Epidemiol Biomarkers Prev 2007
330
14

Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones.
H Tsuda, T Takarabe, T Hasegawa, T Murata, S Hirohashi. Hum Pathol 1999
93
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.